CME/CE - PACE-CME

Episodes 113-128 of 142

Diagnosing HCM: What a cardiologist needs to know
Diagnosing HCM: What a cardiologist needs to know
MinuteCE®
Diagnosing HCM: What a cardiologist needs to know
1.00 program credit
- Aleš Linhart, MD, PhD
1.00 program credit
Challenges in ASCVD reduction and TG-related risk
Challenges in ASCVD reduction and TG-related risk
MinuteCE®
Challenges in ASCVD reduction and TG-related risk
1.00 program credit
- Erik Stroes
1.00 program credit
Perspectives on the results of recent clinical outcomes trials with EPA prevention
Perspectives on the results of recent clinical outcomes trials with EPA prevention
MinuteCE®
Perspectives on the results of recent clinical outcomes trials with EPA prevention
1.00 program credit
- P. Gabriel Steg, MD
1.00 program credit
Integrating icosapent ethyl in cardiovascular risk reduction strategies: Practical guidance
Integrating icosapent ethyl in cardiovascular risk reduction strategies: Practical guidance
MinuteCE®
Integrating icosapent ethyl in cardiovascular risk reduction strategies: Practical guidance
1.00 program credit
- Pam R. Taub, MD, FACC, FASPC
1.00 program credit
MinuteCE®
Improving the management of patients with atherosclerotic cardiovascular disease - The evolving role of icosapent ethyl
1.00 credit 3 episodes
- Erik Stroes
- P. Gabriel Steg, MD
- Pam R. Taub, MD, FACC, FASPC
1.00 credit 3 episodes
Novel oral pathways in LDL-C lowering therapy: The new promise of CETPi
Novel oral pathways in LDL-C lowering therapy: The new promise of CETPi
MinuteCE®
Novel oral pathways in LDL-C lowering therapy: The new promise of CETPi
1.00 program credit
- Erin Michos
1.00 program credit
Oral cholesterol-lowering therapies: The basis of prevention
Oral cholesterol-lowering therapies: The basis of prevention
MinuteCE®
Oral cholesterol-lowering therapies: The basis of prevention
1.00 program credit
- Lale Tokgözoğlu, MD
1.00 program credit
PCSK9i: Benefits across the spectrum of cardiovascular disease
PCSK9i: Benefits across the spectrum of cardiovascular disease
MinuteCE®
PCSK9i: Benefits across the spectrum of cardiovascular disease
1.00 program credit
- Prof. dr. Fabrice Martens
1.00 program credit
MinuteCE®
The LDL-c challenge in high cardiovascular risk - Integrating innovative therapies in clinical management
1.00 credit 4 episodes
- Kausik Ray, MBChB, MD, MPhil
- Lale Tokgözoğlu, MD
- Prof. dr. Fabrice Martens
- Erin Michos
1.00 credit 4 episodes
The evolving need and challenges to reach LDL-c targets in high-risk patients
The evolving need and challenges to reach LDL-c targets in high-risk patients
MinuteCE®
The evolving need and challenges to reach LDL-c targets in high-risk patients
1.00 program credit
- Kausik Ray, MBChB, MD, MPhil
1.00 program credit
MinuteCE®
Role of CETP inhibitors in cardiovascular risk reduction - Will lessons from the past lead to future success?
1.00 credit 3 episodes
- Stephen Nicholls, FRACP, FACC, FESC, FAHA
- Prof. John Kastelein, Chief Scientific Officer, NewAmsterdam Pharma
- Roxana Mehran, MD
1.00 credit 3 episodes
Exploring the role of a novel CETP inhibitor in lipid management
Exploring the role of a novel CETP inhibitor in lipid management
MinuteCE®
Exploring the role of a novel CETP inhibitor in lipid management
1.00 program credit
- Roxana Mehran, MD
1.00 program credit
Unmet needs in lowering LDL-c
Unmet needs in lowering LDL-c
MinuteCE®
Unmet needs in lowering LDL-c
1.00 program credit
- Stephen Nicholls, FRACP, FACC, FESC, FAHA
1.00 program credit
New insights on CETP inhibition from genetic research and clinical trials
New insights on CETP inhibition from genetic research and clinical trials
MinuteCE®
New insights on CETP inhibition from genetic research and clinical trials
1.00 program credit
- Prof. John Kastelein, Chief Scientific Officer, NewAmsterdam Pharma
1.00 program credit
Diagnostic challenges for symptomatic obstructive HCM
Diagnostic challenges for symptomatic obstructive HCM
MinuteCE®
Diagnostic challenges for symptomatic obstructive HCM
1.00 program credit
- Pablo García-Pavía, MD, PhD
1.00 program credit
Improving quality of life in patients with HCM
Improving quality of life in patients with HCM
MinuteCE®
Improving quality of life in patients with HCM
1.00 program credit
- Carolyn Ho, MD
1.00 program credit

8/7